...
首页> 外文期刊>The Journal of Nuclear Medicine >Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner
【24h】

Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner

机译:11C-(+)-PHNO与人D2 / D3多巴胺受体的高分辨率结合层析成像PET扫描仪的参数成像和重新测试变异性

获取原文

摘要

id="p-2">11C-(+)-4-propyl-9-hydroxynaphthoxazine (11C-(+)-PHNO) is an agonist radioligand for imaging dopamine D2 and D3 receptors in the human brain with PET. In this study we evaluated the reproducibility of 11C-(+)-PHNO binding parameters using a within-day design and assessed parametric imaging methods. >Methods: Repeated studies were performed in 8 subjects, with simultaneous measurement of the arterial input function and plasma free fraction. Two 11C-(+)-PHNO scans for the same subject were separated by 5.4 ?± 0.7 h. After compartment models were evaluated, 11C-(+)-PHNO volumes of distribution (VT) and binding potentials relative to the concentration of tracer in plasma (BPP), nondisplaceable tracer in tissue (BPND), and free tracer in tissue (BPF) were quantified using the multilinear analysis MA1 method, with the cerebellum as the reference region. Parametric images of BPND were also computed using the simplified reference tissue model (SRTM) and SRTM2. >Results: The test-retest variability of 11C-(+)-PHNO BPND was 9% in D2-rich regions (caudate and putamen). Among D3-rich regions, variability was low in the pallidum (6%) but higher in substantia nigra (19%), thalamus (14%), and hypothalamus (21%). No significant mass carry-over effect was observed in D3-rich regions, although a trend in BPND was present in the substantia nigra (a?’14% ?± 15%). Because of the relatively fast kinetics, low-noise BPND parametric images were obtained with both SRTM and SRTM2 without spatial smoothing. >Conclusion: 11C-(+)-PHNO can be used to compute low-noise parametric images in both D2- and D3-rich regions in humans.
机译:id =“ p-2”> 11 C-(+)-4-丙基-9-羟基萘恶嗪( 11 C-(+)-PHNO)是激动剂放射性配体通过PET对人脑中的多巴胺D 2 和D 3 受体进行成像。在这项研究中,我们使用日内设计和评估的参数成像方法评估了 11 C-(+)-PHNO结合参数的可再现性。 >方法:在8位受试者中进行了重复研究,同时测量了动脉输入功能和血浆游离分数。同一对象的两次 11 C-(+)-PHNO扫描相距5.4±0.7小时。评估隔室模型后, 11 C-(+)-PHNO的分布体积( V T )和结合电位相对于血浆中的示踪剂( BP P ),组织中不可置换的示踪剂( BP ND )和组织中的游离示踪剂( BP F )采用多线性分析MA1方法定量,以小脑为参考区域。还使用简化的参考组织模型(SRTM)和SRTM2计算了 BP ND 的参数图像。 >结果: 11 C-(+)-PHNO BP ND 的重测变异率为9% D 2 丰富的区域(尾状和壳状)。在富含D 3 的区域中,苍白球的变异性较低(6%),而黑质(19%),丘脑(14%)和下丘脑(21%)的变异性较高。尽管黑质中存在 BP ND 的趋势,但在富含D 3 的区域中未观察到明显的质量残留效应( a≥14%≤±15%)。由于动力学相对较快,因此在没有空间平滑的情况下,使用SRTM和SRTM2均获得了低噪声 BP ND 参数图像。 >结论: 11 C-(+)-PHNO可用于计算D 2 -和D 3 丰富的区域。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号